Adult population: The undesirable effects listed in the table as follows have been reported during clinical trials (including 600 adult patients) and post-marketing use. Generally, adverse reactions have been minor and transitory and have mainly concerned the gastrointestinal system: See Table 1.

Paediatric population: The undesirable effects listed in the table as follows have been reported during clinical trials including 147 children aged from 6 months to 15 years and post-marketing use. As in adult population, adverse reactions have generally been minor and transitory and have mainly concerned the gastrointestinal system: See Table 2.

View ADR Reporting Link